Literature DB >> 2314592

Juvenile multiple sclerosis-like episodes associated with a defect of mitochondrial beta oxidation.

B R Powell1, N G Kennaway, W J Rhead, C J Reece, T G Burlingame, N R Buist.   

Abstract

We describe a young girl who presented with recurrent episodes of central nervous system (CNS) demyelination mimicking multiple sclerosis. Metabolic evaluations and decreased oxidation of [9,10(n)-3H] palmitate demonstrated defective mitochondrial beta oxidation, but complementation studies of the patient's cells, fused with cell lines with known defects of beta oxidation, failed to identify a known disorder. While progressive CNS demyelination has occurred in patients with defective peroxisomal very long-chain fatty acid oxidation, this is the 1st time it has occurred with defective mitochondrial beta oxidation. This patient appears to represent a novel disorder of beta oxidation producing intermittent demyelination with profound CNS symptoms. Recognition of the defect led to appropriate therapy, which caused marked clinical improvement.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2314592     DOI: 10.1212/wnl.40.3_part_1.487

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Neuropsychiatric manifestations of defect in mitochondrial beta oxidation response to riboflavin.

Authors:  W J Triggs; C R Roe; W J Rhead; S K Hanson; S N Lin; L J Willmore
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

2.  Proteomic analysis of demyelinated and remyelinating brain tissue following dietary cuprizone administration.

Authors:  Sean R Werner; Joy K Saha; Carol L Broderick; Eugene Y Zhen; Richard E Higgs; Kevin L Duffin; Rosamund C Smith
Journal:  J Mol Neurosci       Date:  2010-04-17       Impact factor: 3.444

3.  Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis.

Authors:  L Claudio; C S Raine; C F Brosnan
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study.

Authors:  Vijitha K Senanayake; Wei Jin; Asuka Mochizuki; Bassirou Chitou; Dayan B Goodenowe
Journal:  BMC Neurol       Date:  2015-08-27       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.